Carregant...
LAMA2 regulates the fate commitment of mesenchymal stem cells via hedgehog signaling
BACKGROUND: Bone defects are a common clinical condition that has gained an increasing amount of attention in recent years. Causes of bone defect include tumors, inflammation, and fractures. Bone tissue engineering is a novel treatment of bone defect, and human mesenchymal stem cells (hMSCs) are the...
Guardat en:
| Publicat a: | Stem Cell Res Ther |
|---|---|
| Autors principals: | , , , , , , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
BioMed Central
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7093965/ https://ncbi.nlm.nih.gov/pubmed/32213190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13287-020-01631-9 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|